SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-009845
Filing Date
2023-05-15
Accepted
2023-05-15 16:12:45
Documents
83
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cara-20230331x10q.htm   iXBRL 10-Q 1834237
2 EX-31.1 cara-20230331xex31d1.htm EX-31.1 12225
3 EX-31.2 cara-20230331xex31d2.htm EX-31.2 12032
4 EX-32.1 cara-20230331xex32d1.htm EX-32.1 10371
  Complete submission text file 0001558370-23-009845.txt   8526003

Data Files

Seq Description Document Type Size
5 EX-101.SCH cara-20230331.xsd EX-101.SCH 60161
6 EX-101.CAL cara-20230331_cal.xml EX-101.CAL 52762
7 EX-101.DEF cara-20230331_def.xml EX-101.DEF 293372
8 EX-101.LAB cara-20230331_lab.xml EX-101.LAB 480351
9 EX-101.PRE cara-20230331_pre.xml EX-101.PRE 429805
77 EXTRACTED XBRL INSTANCE DOCUMENT cara-20230331x10q_htm.xml XML 1576674
Mailing Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902
Business Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902 203-406-3700
Cara Therapeutics, Inc. (Filer) CIK: 0001346830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36279 | Film No.: 23922392
SIC: 2834 Pharmaceutical Preparations